Adam Abram, MD
Otolaryngology/Facial Plastic Surgery · Columbia, SCNPI 1649230632
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $491 of the $547 with a category attached, or 89.8%. 9 manufacturers reported payments, led by Integra Lifesciences Corporation at 30.6% of the total. 2025 is the largest year on record at $338, 9.9 times the $34 reported in 2019.
Across 16 payments — averaging $34.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$167
- Stryker$99
- Sanofi$77
- GSK$59
- Regeneron Healthcare Solutions, Inc.$56
- Acera Surgical, Inc.$31
- plus $59 from 3 others
What the payments were for
- Food & beverage$49190%
- Education$5610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 2 | $167 |
| Stryker | 3 | $99 |
| Sanofi | 3 | $77 |
| GSK | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 1 | $56 |
| Acera Surgical, Inc. | 1 | $31 |
| Verastem, Inc. | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Intersect ENT, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acclarent Aera$150
- Inspira Air$150
- RELIEVA SPINPLUS NAV$150
- TruDi Probe$150
How this compares
Too few otolaryngology/facial plastic surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 190 | $4,419 |
| Ipratropium Bromide | 119 | $3,516 |
| Fluticasone Propionate | 217 | $2,278 |
| Mometasone Furoate | 15 | $997 |
| Omeprazole | 37 | $552 |
| Ofloxacin | 20 | $384 |
| Prednisone | 66 | $155 |
| Mupirocin | 14 | $78 |
| Amoxicillin | 22 | $73 |
| Ciprofloxacin Hcl | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Columbia
- William GilesColumbia$947
- Michael PetersLittle River$29K
- Thomas SellnerGreenville$3K
- Sheila PutmanMyrtle Beach$3K
- Paul EvangelistiSumter$2K
- Helen MosesSumter$1K
- Nicholas LukacsFort Mill$1K
- Hans CarlsonGreenville$1K
- Gregory EsselmanAiken$822
- Joseph RussellNorth Charleston$728
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.